Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Hollman Meyer currently holds 83,095 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Hollman Meyer has been a net seller of JANX stock. They have purchased $0 and sold $3.0M worth of shares.
Andrew Hollman Meyer's most recent insider trade was on Jan 2, 2026, when they sold 1,879 shares at $13.73 per share.
Andrew Hollman Meyer serves as Executive at Janux Therapeutics, Inc. (JANX). They have executed 15 insider transactions totaling $3.0M over their tenure at the company.
Andrew Hollman Meyer holds the position of Executive at Janux Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Andrew Hollman Meyer has shown a selling trading pattern, with $0 in total purchases and $3.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew Hollman Meyer was on Sep 27, 2024, when they sold $2.3M worth of JANX shares. This transaction involved 50,000 shares at $45.96 per share.
Andrew Hollman Meyer currently owns 83,095 shares of Janux Therapeutics, Inc. (JANX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Hollman Meyer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Hollman Meyer has 15 Form 4 filings on record as an insider at Janux Therapeutics, Inc..
Set alerts for Andrew Hollman Meyer and 40,000+ other insiders.